Mitochondria-targeted peptide SS-31 attenuates renal injury via an antioxidant effect in diabetic nephropathy (Q46616439)

23 December 2017

title

Mitochondria-targeted peptide SS-31 attenuates renal injury via an antioxidant effect in diabetic nephropathy (English)

1 reference

23 December 2017

1 reference

Yanjuan Hou

1

1 reference

23 December 2017

Shuangcheng Li

2

1 reference

23 December 2017

Ming Wu

3

1 reference

23 December 2017

Jinying Wei

4

1 reference

23 December 2017

Yunzhuo Ren

5

1 reference

23 December 2017

Chunyang Du

6

1 reference

23 December 2017

Haijiang Wu

7

1 reference

23 December 2017

Caili Han

8

1 reference

23 December 2017

Huijun Duan

9

1 reference

23 December 2017

Yonghong Shi

10

1 reference

23 December 2017

publication date

30 December 2015

1 reference

23 December 2017

American Journal of Physiology - Renal Physiology

published in

1 reference

23 December 2017

volume

310

1 reference

23 December 2017

issue

6

1 reference

23 December 2017

page(s)

F547-59

1 reference

23 December 2017

Expression, localization, and function of the thioredoxin system in diabetic nephropathy

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00574.2014

Inhibition of p38MAPK increases adipogenesis from embryonic to adult stages

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00574.2014

The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00574.2014

Activated protein C ameliorates diabetic nephropathy by epigenetically inhibiting the redox enzyme p66Shc

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00574.2014

Reactive oxygen species promote caspase-12 expression and tubular apoptosis in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00574.2014

Biochemistry and molecular cell biology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00574.2014

RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00574.2014

Overexpression of manganese superoxide dismutase protects against ATP depletion-mediated cell death of proximal tubule cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00574.2014

Mitochondrial targeted antioxidant Peptide ameliorates hypertensive cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00574.2014

Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00574.2014

Oxidative stress as a major culprit in kidney disease in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00574.2014

ADAM17 mediates Nox4 expression and NADPH oxidase activity in the kidney cortex of OVE26 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00574.2014

Nox as a target for diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00574.2014

Nox4 and diabetic nephropathy: with a friend like this, who needs enemies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00574.2014

Targeting NADPH oxidase with a novel dual Nox1/Nox4 inhibitor attenuates renal pathology in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00574.2014

Role of reactive oxygen species in the pathogenesis of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00574.2014

Antioxidants attenuate high glucose-induced hypertrophic growth in renal tubular epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00574.2014

Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00574.2014

FR167653 inhibits fibronectin expression and apoptosis in diabetic glomeruli and in high-glucose-stimulated mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00574.2014

High glucose promotes mesangial cell apoptosis by oxidant-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00574.2014

p38 MAPK and MAPK kinase 3/6 mRNA and activities are increased in early diabetic glomeruli

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00574.2014

Mitochondria-targeted antioxidant peptide SS31 attenuates high glucose-induced injury on human retinal endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00574.2014

Methylglyoxal induces apoptosis through activation of p38 mitogen-activated protein kinase in rat mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00574.2014

High glucose evokes an intrinsic proapoptotic signaling pathway in mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00574.2014

A novel cell-permeable antioxidant peptide decreases renal tubular apoptosis and damage in unilateral ureteral obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00574.2014

Mitochondrial superoxide plays a crucial role in the development of mitochondrial dysfunction during high glucose exposure in rat renal proximal tubular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00574.2014

Vasohibin-1, a negative feedback regulator of angiogenesis, ameliorates renal alterations in a mouse model of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00574.2014

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00574.2014

Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00574.2014

Reactive oxygen species, antioxidants, and the mammalian thioredoxin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00574.2014

Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00574.2014

JC-1, but not DiOC6(3) or rhodamine 123, is a reliable fluorescent probe to assess delta psi changes in intact cells: implications for studies on mitochondrial functionality during apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00574.2014

BASP1 promotes apoptosis in diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00574.2014

Extension of murine life span by overexpression of catalase targeted to mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00574.2014

Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: implications in type 2 diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00574.2014

Knockdown of thioredoxin interacting protein attenuates high glucose-induced apoptosis and activation of ASK1 in mouse mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00574.2014

Signs of nephropathy may occur early in young adults with diabetes despite modern diabetes management: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00574.2014

Cell-permeable, mitochondrial-targeted, peptide antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00574.2014

Mitochondria-targeted peptide accelerates ATP recovery and reduces ischemic kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00574.2014

Diabetic nephropathy and antioxidants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00574.2014

Mitochondrial Targeting with Antioxidant Peptide SS-31 Prevents Mitochondrial Depolarization, Reduces Islet Cell Apoptosis, Increases Islet Cell Yield, and Improves Posttransplantation Function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00574.2014

Oxidative stress: the special case of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00574.2014

Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00574.2014

Therapeutic approach for diabetic nephropathy using gene delivery of translocase of inner mitochondrial membrane 44 by reducing mitochondrial superoxide production

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00574.2014

Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00574.2014

Mitochondria-targeted peptide prevents mitochondrial depolarization and apoptosis induced by tert-butyl hydroperoxide in neuronal cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00574.2014

Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00574.2014

10.1152/AJPRENAL.00574.2014

21 January 2018

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017